AzTrials
AzTrials

Primary Stability of ImplantsNCT03661957

Non Grafted Maxillary Sinus Floor Elevation With Implant Placement Versus the Use of Short Endosseous Implants

A study testing Non grafted maxillary sinus floor elevation with simultaneous implant placement and using short dental implants for posterior atrophic maxilla in people with Primary Stability of Implants and Marginal Bone Loss, run by Cairo University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Assessment the need for sinus floor elevation when restoring atrophic posterior maxilla or it will be enough to use of short implant Read more about this study

Who is it for?
Ages 25 to 60 yearsHealthy volunteers can take part
What is being tested?
Non grafted maxillary sinus floor elevation with simultaneous implant placement and using short dental implants for posterior atrophic maxilla
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteEgypt
Study dates
Sep 2018to Apr 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Patients with partially edentulous in the posterior area of the maxilla, with a residual ridge that allowed insertion of ≤8 mm length implants.
  • Both sexes.
  • No intraoral soft and hard tissue pathology
  • No systemic condition that contraindicate implant placement.

Who cannot join

  • Sinus pathology.
  • Heavy smokers more than 20 cigarettes per day.
  • Patients with systemic disease that may affect normal healing.
  • Psychiatric problems
  • Disorders to implant are related to history of radiation therapy to the head and neck neoplasia, or bone augmentation to implant site
  • Immunodeficiency pathology, bruxism, stress situation (socially or professionally), emotional instability, and unrealistic aesthetic demands.

Trial locations and contacts

1 site in 1 country.

Egypt1 site, 1 recruiting
  • Ahmed Maher Mansour

    Cairo

    ahmed maher mansour, BDS, 00201092955447, a7mad.maher10@gmail.com

    Recruiting

Other trials in Egypt

About this study

Official title: Non Grafted Maxillary Sinus Floor Elevation With Simultaneous Implant Placement Versus the Use of Short Endosseous Implants

Assessment the need for sinus floor elevation when restoring atrophic posterior maxilla or it will be enough to use of short implant

Being tested
Non grafted maxillary sinus floor elevation with simultaneous implant placement, using short dental implants for posterior atrophic maxilla

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Non grafted maxillary sinus floor elevation with simultaneous implant placementProcedure or surgery

    lateral window for sinus elevation ,membrane elevation ,implant placement , membrane for window closure

  • using short dental implants for posterior atrophic maxillaProcedure or surgery

    placement of short dental implant with bone height below 8mm

Study groups in NCT03661957
Study groupRoleWhat they receive
Non grafted maxillary sinus floor elevation with implant pacemActive comparatorNot described
Receives: Procedure: Non grafted maxillary sinus floor elevation with simultaneous implant placement
using short dental implants for posterior atrophic maxillaExperimentalNot described
Receives: Procedure: using short dental implants for posterior atrophic maxilla

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. primary stability

    measuring primary stability using osstel

    Measured: 6 months

Secondary outcomes (1)
  1. marginal bone loss

    measuring marginal bone loss using cone beam ct

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Sep 2018
  2. Study startSep 2018 (estimated)
  3. Primary completionDec 2018 (estimated)
  4. Study completionApr 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
10 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03661957
Sponsor's protocol ID
cairo university 99
Status last verified
Sep 2018
First submitted
2 Sep 2018
Last updated
7 Sep 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Non grafted maxillary sinus floor elevation with simultaneous implant placement and using short dental implants for posterior atrophic maxilla in people with Primary Stability of Implants and Marginal Bone Loss, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Sep 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

primary stability (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Sep 2018.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in